These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 21741859

  • 1. Association between circulating electronegative low-density lipoproteins and serum ferritin in hemodialysis patients: a pilot study.
    Lobo JC, Farage NE, Abdalla DS, Velarde LG, Torres JP, Mafra D.
    J Ren Nutr; 2012 May; 22(3):350-6. PubMed ID: 21741859
    [Abstract] [Full Text] [Related]

  • 2. Increased electronegative LDL and decreased antibodies against electronegative LDL levels correlate with inflammatory markers and adhesion molecules in hemodialysed patients.
    Lobo JC, Mafra D, Farage NE, Faulin Tdo E, Abdalla DS, de Nóbrega AC, Torres JP.
    Clin Chim Acta; 2011 Sep 18; 412(19-20):1788-92. PubMed ID: 21676364
    [Abstract] [Full Text] [Related]

  • 3. Reduced plasma zinc levels, lipid peroxidation, and inflammation biomarkers levels in hemodialysis patients: implications to cardiovascular mortality.
    Lobo JC, Stockler-Pinto MB, Farage NE, Faulin Tdo E, Abdalla DS, Torres JP, Velarde LG, Mafra D.
    Ren Fail; 2013 Sep 18; 35(5):680-5. PubMed ID: 23650973
    [Abstract] [Full Text] [Related]

  • 4. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J, Santos F, Grosso D, Lima R, Barreira AL, Leite M, Mafra D, Abdalla DS.
    Nephron Clin Pract; 2008 Sep 18; 108(4):c298-304. PubMed ID: 18434752
    [Abstract] [Full Text] [Related]

  • 5. Apelin: a peptide involved in cardiovascular risk in hemodialysis patients?
    Leal VO, Lobo JC, Stockler-Pinto MB, Farage NE, Calixto A, Geloneze B, Mafra D.
    Ren Fail; 2012 Sep 18; 34(5):577-81. PubMed ID: 22417287
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P, Sarafidis PA, Rudenco I, Raptis V, Makedou K, Makedou A, Grekas DM.
    Am J Nephrol; 2007 Sep 18; 27(6):572-9. PubMed ID: 17804904
    [Abstract] [Full Text] [Related]

  • 9. Alpha-tocopherol supplementation decreases electronegative low-density lipoprotein concentration [LDL(-)] in haemodialysis patients.
    Mafra D, Santos FR, Lobo JC, de Mattos Grosso D, Barreira AL, Velarde LG, Abdalla DS, Leite M.
    Nephrol Dial Transplant; 2009 May 18; 24(5):1587-92. PubMed ID: 19176686
    [Abstract] [Full Text] [Related]

  • 10. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
    Peng Y, Liu H, Liu F, Ouyang L, Cheng M, Gao L, Pan F, Liu Y, Chen X, Li J.
    Nephrology (Carlton); 2008 Oct 18; 13(7):579-86. PubMed ID: 19161364
    [Abstract] [Full Text] [Related]

  • 11. Serum oxidized low-density lipoprotein is inversely correlated to telomerase activity in peripheral blood mononuclear cells of haemodialysis patients.
    Tsirpanlis G, Chatzipanagiotou S, Boufidou F, Kordinas V, Zoga M, Alevyzaki F, Stamatelou K, Frangou E, Savva L, Nicolaou C.
    Nephrology (Carlton); 2006 Dec 18; 11(6):506-9. PubMed ID: 17199788
    [Abstract] [Full Text] [Related]

  • 12. Protein oxidative stress and dyslipidemia in dialysis patients.
    Marques de Mattos A, Marino LV, Ovidio PP, Jordão AA, Almeida CC, Chiarello PG.
    Ther Apher Dial; 2012 Feb 18; 16(1):68-74. PubMed ID: 22248198
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Ferritin, oxidative stress and coronary atherosclerosis].
    Kraml P, Potocková J, Koprivová H, Stípek S, Crkovská J, Zima T, Andĕl M.
    Vnitr Lek; 2004 Mar 18; 50(3):197-202. PubMed ID: 15125369
    [Abstract] [Full Text] [Related]

  • 15. The newly identified anorexigenic adipokine nesfatin-1 in hemodialysis patients: Are there associations with food intake, body composition and inflammation?
    Saldanha JF, Carrero JJ, Lobo JC, Stockler-Pinto MB, Leal VO, Calixto A, Geloneze B, Mafra D.
    Regul Pept; 2012 Jan 10; 173(1-3):82-5. PubMed ID: 22036920
    [Abstract] [Full Text] [Related]

  • 16. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study.
    Anraku M, Kitamura K, Shintomo R, Takeuchi K, Ikeda H, Nagano J, Ko T, Mera K, Tomita K, Otagiri M.
    Clin Biochem; 2008 Oct 10; 41(14-15):1168-74. PubMed ID: 18692036
    [Abstract] [Full Text] [Related]

  • 17. Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia.
    Shakeri A, Tabibi H, Hedayati M.
    Hemodial Int; 2010 Oct 10; 14(4):498-504. PubMed ID: 20812958
    [Abstract] [Full Text] [Related]

  • 18. Impact of iron treatment on immune effector function and cellular iron status of circulating monocytes in dialysis patients.
    Sonnweber T, Theurl I, Seifert M, Schroll A, Eder S, Mayer G, Weiss G.
    Nephrol Dial Transplant; 2011 Mar 10; 26(3):977-87. PubMed ID: 20826742
    [Abstract] [Full Text] [Related]

  • 19. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients.
    Arikan H, Koc M, Sari H, Tuglular S, Ozener C, Akoglu E.
    Ren Fail; 2007 Mar 10; 29(6):713-9. PubMed ID: 17763167
    [Abstract] [Full Text] [Related]

  • 20. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC, Hung SC, Tarng DC.
    Am J Kidney Dis; 2006 Jun 10; 47(6):1036-44. PubMed ID: 16731299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.